Inspire Medical Systems Inc INSP
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if INSP is a good fit for your portfolio.
News
-
Inspire Medical Systems, Inc. to Report First Quarter 2024 Financial Results on May 7, 2024
-
Investigation Alert: Cummins, Apellis Pharmaceuticals, Inspire Medical, and Applied Digital - Johnson Fistel, LLP Encourages Long-Term Investors to Submit Their Information Below
-
Investigation Alert Driven Brands Holdings, Apellis Pharmaceuticals, Inspire Medical, and Applied Digital: Johnson Fistel, LLP Encourages Long-Term Investors to Submit Their Information Below
-
Inspire Medical Systems, Inc. to Present at the KeyBanc Life Sciences & MedTech Investor Forum
-
INSPIRE MEDICAL ALERT: Bragar Eagel & Squire, P.C. is Investigating Inspire Medical Systems, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
-
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Inspire Medical Systems, Inc. - INSP
-
DEADLINE ALERT for GDHG, LOVE, INSP, and DRVN: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
-
INSPIRE MEDICAL 96 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Inspire Medical Systems, Inc. - INSP
Trading Information
- Previous Close Price
- $231.01
- Day Range
- $233.57–244.80
- 52-Week Range
- $123.27–330.00
- Bid/Ask
- $94.98 / $377.54
- Market Cap
- $7.19 Bil
- Volume/Avg
- 604,213 / 515,108
Key Statistics
- Price/Earnings (Normalized)
- 157.94
- Price/Sales
- 11.14
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 1,011
- Website
- https://www.inspiresleep.com
Comparables
Valuation
Metric
|
INSP
|
SIBN
|
ZIMV
|
---|---|---|---|
Price/Earnings (Normalized) | 157.94 | — | 9.70 |
Price/Book Value | 12.26 | 3.66 | 1.05 |
Price/Sales | 11.14 | 4.22 | 0.91 |
Price/Cash Flow | 106.33 | — | 12.30 |
Price/Earnings
INSP
SIBN
ZIMV
Financial Strength
Metric
|
INSP
|
SIBN
|
ZIMV
|
---|---|---|---|
Quick Ratio | 7.05 | 8.01 | 0.84 |
Current Ratio | 7.60 | 9.01 | 2.78 |
Interest Coverage | — | −13.52 | −1.51 |
Quick Ratio
INSP
SIBN
ZIMV
Profitability
Metric
|
INSP
|
SIBN
|
ZIMV
|
---|---|---|---|
Return on Assets (Normalized) | 7.16% | −8.97% | 14.12% |
Return on Equity (Normalized) | 8.31% | −12.61% | 31.63% |
Return on Invested Capital (Normalized) | 5.07% | −11.78% | 18.79% |
Return on Assets
INSP
SIBN
ZIMV
Medical Devices Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
ABT
| Abbott Laboratories | Nhlpyhn | Mbqcj | $185.4 Bil | |
SYK
| Stryker Corp | Jzdgvvpnd | Wmxzf | $127.7 Bil | |
BSX
| Boston Scientific Corp | Dktdzpjb | Vknhl | $107.6 Bil | |
MDT
| Medtronic PLC | Gfykxzmf | Fnqyr | $105.9 Bil | |
DXCM
| DexCom Inc | Fsbtxxlwys | Xhlh | $54.7 Bil | |
EW
| Edwards Lifesciences Corp | Qssshtkqh | Xgwdmyb | $52.0 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Dktvwxvj | Qnb | $24.6 Bil | |
ALGN
| Align Technology Inc | Httszbzcw | Ffsqh | $23.4 Bil | |
PHG
| Koninklijke Philips NV ADR | Cmnntfcfh | Mssmmql | $18.7 Bil | |
PODD
| Insulet Corp | Dvcgfxdp | Vdrxnzc | $11.6 Bil |